Phase I/II, Randomized, Double-Blind, Study of the Progenitor Cell Mobilizing Effects of Imprime PGG™ Injection Administered at Varied Dosing Regimens With G-CSF Versus G-CSF Alone
Clinical trial NCT00542529 · COMPLETED
Trial details
- NCT number
- NCT00542529
- Sponsor
- HiberCell, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.